INMODE LTD (INMD) Stock Price, Forecast & Analysis

NASDAQ:INMD • IL0011595993

13.6 USD
-0.04 (-0.29%)
At close: Mar 3, 2026
13.58 USD
-0.02 (-0.15%)
After Hours: 3/3/2026, 8:19:50 PM

INMD Key Statistics, Chart & Performance

Key Statistics
Market Cap859.66M
Revenue(TTM)370.50M
Net Income(TTM)93.83M
Shares63.21M
Float56.48M
52 Week High19.78
52 Week Low13.14
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)1.62
PE8.4
Fwd PE8.09
Earnings (Next)04-27
IPO2019-08-08
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
INMD short term performance overview.The bars show the price performance of INMD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15

INMD long term performance overview.The bars show the price performance of INMD in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of INMD is 13.6 USD. In the past month the price decreased by -18.17%. In the past year, price decreased by -28.5%.

INMODE LTD / INMD Daily stock chart

INMD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
INMD Full Technical Analysis Report

INMD Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to INMD. INMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
INMD Full Fundamental Analysis Report

INMD Financial Highlights

Over the last trailing twelve months INMD reported a non-GAAP Earnings per Share(EPS) of 1.62. The EPS decreased by -8.99% compared to the year before.


Industry RankSector Rank
PM (TTM) 25.33%
ROA 12.24%
ROE 13.73%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%9.52%
Sales Q2Q%6.13%
EPS 1Y (TTM)-8.99%
Revenue 1Y (TTM)-6.16%
INMD financials

INMD Forecast & Estimates

14 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 26% is expected in the next year compared to the current price of 13.6.

For the next year, analysts expect an EPS growth of 3.73% and a revenue growth 1.75% for INMD


Analysts
Analysts74.29
Price Target17.14 (26.03%)
EPS Next Y3.73%
Revenue Next Year1.75%
INMD Analyst EstimatesINMD Analyst Ratings

INMD Ownership

Ownership
Inst Owners59.58%
Ins Owners10.65%
Short Float %5.89%
Short Ratio3.17
INMD Ownership

INMD Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19.78198.44B
ISRG INTUITIVE SURGICAL INC48.67176.233B
SYK STRYKER CORP25.44148.004B
BSX BOSTON SCIENTIFIC CORP21.09113.036B
IDXX IDEXX LABORATORIES INC42.8950.84B
EW EDWARDS LIFESCIENCES CORP28.6850.591B
BDX BECTON DICKINSON AND CO11.0650.298B
RMD RESMED INC21.0337.497B
GEHC GE HEALTHCARE TECHNOLOGY15.5636.533B
DXCM DEXCOM INC28.9428.776B

About INMD

Company Profile

INMD logo image InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

Company Info

INMODE LTD

Tavor Building, Sha'ar Yokneam, Pob 533

Yokneam 2069200 IL

CEO: Moshe Mizrahy

Employees: 599

INMD Company Website

INMD Investor Relations

Phone: 97249097470

INMODE LTD / INMD FAQ

Can you describe the business of INMODE LTD?

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.


Can you provide the latest stock price for INMODE LTD?

The current stock price of INMD is 13.6 USD. The price decreased by -0.29% in the last trading session.


Does INMODE LTD pay dividends?

INMD does not pay a dividend.


How is the ChartMill rating for INMODE LTD?

INMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


What do analysts say about INMODE LTD (INMD) stock?

14 analysts have analysed INMD and the average price target is 17.14 USD. This implies a price increase of 26% is expected in the next year compared to the current price of 13.6.


Can you provide the growth outlook for INMODE LTD?

The Revenue of INMODE LTD (INMD) is expected to grow by 1.75% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the number of employees for INMODE LTD?

INMODE LTD (INMD) currently has 599 employees.